Understanding of"Prescribing drugs in pregnancy and breastfeeding:immunomodulatory anti-rheumatic drugs and corticosteroids"guideline by the British Society of Rheumatology in 2022
The British Society for Rheumatology(BSR)published"Prescribing drugs in pregnancy and breastfeeding:immunomodulatory anti-rheumatic drugs and corticosteroids"guideline on November 2,2022,the guideline provides the guidance suggestion on prescribing antirheumatic drugs during pregnant period and lactation period,the contents include the safety of antimalarials;corticosteroids;conventional synthetic DMARDs(csDMARDs)and immunosuppressive therapies;biologic DMARDs(bDMARDs);and targeted syn-thetic DMARDs(tsDMARDs)during pregnant period and lactation period,the recommendations for father medication,and replenish the recommendations for bMDARDs and tsDMARDs in order to provide a basis for the medical staff to use these kinds of drugs.